1873 related articles for article (PubMed ID: 19296974)
21. Troponin T and N-terminal pro-brain natriuretic peptide changes in patients undergoing transurethral resection of the prostate.
Manikandan R; Nathaniel C; Lewis P; Brough RJ; Adeyoju A; Brown SC; O'Reilly PH; Collins GN
J Urol; 2005 Nov; 174(5):1892-5; discussion 1895. PubMed ID: 16217331
[TBL] [Abstract][Full Text] [Related]
22. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.
Bachmann A; Schürch L; Ruszat R; Wyler SF; Seifert HH; Müller A; Lehmann K; Sulser T
Eur Urol; 2005 Dec; 48(6):965-71; discussion 972. PubMed ID: 16126327
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of transurethral resection of the prostate in the patients with weak bladder contractility index.
Han DH; Jeong YS; Choo MS; Lee KS
Urology; 2008 Apr; 71(4):657-61. PubMed ID: 18313105
[TBL] [Abstract][Full Text] [Related]
24. [Clinical analysis and management of disappointing early urination after TURP].
Wang YC; Lu Y; Song YS
Zhonghua Nan Ke Xue; 2009 Jan; 15(1):48-50. PubMed ID: 19288750
[TBL] [Abstract][Full Text] [Related]
25. Photoselective prostatic vaporization for bladder outlet obstruction: 12-month evaluation of storage and voiding symptoms.
De Nunzio C; Miano R; Trucchi A; Miano L; Franco G; Squillacciotti S; Tubaro A
J Urol; 2010 Mar; 183(3):1098-103. PubMed ID: 20092849
[TBL] [Abstract][Full Text] [Related]
26. Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings.
Nitti VW; Kim Y; Combs AJ
J Urol; 1997 Feb; 157(2):600-3. PubMed ID: 8996367
[TBL] [Abstract][Full Text] [Related]
27. A prospective, randomized trial comparing conventional transurethral prostate resection with PlasmaKinetic vaporization of the prostate: physiological changes, early complications and long-term followup.
Hon NH; Brathwaite D; Hussain Z; Ghiblawi S; Brace H; Hayne D; Coppinger SW
J Urol; 2006 Jul; 176(1):205-9. PubMed ID: 16753403
[TBL] [Abstract][Full Text] [Related]
28. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?
Rigatti L; Naspro R; Salonia A; Centemero A; Ghezzi M; Guazzoni G; Briganti A; Rigatti P; Montorsi F
Urology; 2006 Jun; 67(6):1193-8. PubMed ID: 16750253
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
30. Collagen injection therapy for post-prostatectomy incontinence.
Smith DN; Appell RA; Rackley RR; Winters JC
J Urol; 1998 Aug; 160(2):364-7. PubMed ID: 9679878
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcome of simultaneous transurethral resection of bladder tumor and prostate in patients with nonmuscle invasive bladder tumor and bladder outlet obstruction.
Ham WS; Kim WT; Jeon HJ; Lee DH; Choi YD
J Urol; 2009 Apr; 181(4):1594-9; discussion 1599. PubMed ID: 19230913
[TBL] [Abstract][Full Text] [Related]
32. Transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: a preliminary assessment of the Prostalund feedback treatment machine.
Kehinde EO; Abul F
Med Princ Pract; 2005; 14(4):272-6. PubMed ID: 15961940
[TBL] [Abstract][Full Text] [Related]
33. Trans urethral electric vaporisation of prostate as an alternate to trans urethral resection in benign prostatic hyperplasia.
Akhtar MM; Orakzai N; Qureshi AM
J Ayub Med Coll Abbottabad; 2004; 16(4):16-20. PubMed ID: 15762056
[TBL] [Abstract][Full Text] [Related]
34. Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters.
Mock S; Leapman M; Stock RG; Hall SJ; Stone NN
J Urol; 2013 Nov; 190(5):1805-10. PubMed ID: 23669568
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
[TBL] [Abstract][Full Text] [Related]
36. Transurethral resection of the prostate (TURP)--in the treatment of benign prostatic hypertrophy (BPH) in Mekelle, Ethiopia.
Alemu MH
Ethiop Med J; 2009 Jan; 47(1):65-9. PubMed ID: 19743783
[TBL] [Abstract][Full Text] [Related]
37. Effects of simultaneous transurethral resection of prostate and solitary bladder tumors smaller than 3 cm on oncologic results.
Ugurlu O; Gonulalan U; Adsan O; Kosan M; Oztekin V; Cetinkaya M
Urology; 2007 Jul; 70(1):55-9. PubMed ID: 17656208
[TBL] [Abstract][Full Text] [Related]
38. Quantification of voiding dysfunction in patients awaiting transurethral prostatectomy.
Javlé P; Jenkins SA; West C; Parsons KF
J Urol; 1996 Sep; 156(3):1014-8; discussion 1018-9. PubMed ID: 8709299
[TBL] [Abstract][Full Text] [Related]
39. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction.
Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y
Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous transurethral cystolithotripsy with holmium laser enucleation of the prostate: a prospective feasibility study and review of literature.
Shah HN; Hegde SS; Shah JN; Mahajan AP; Bansal MB
BJU Int; 2007 Mar; 99(3):595-600. PubMed ID: 17026589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]